Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Baseline fasting lipids should be recorded for all HIV-infected patients at entry into care
  • If no lipid abnormalities are present, repeat screening should be performed every 6-12 months, or more frequently if risk factors such as obesity, diabetes, fat redistribution, or a family history of dyslipidemia are present

Action required